Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IgNiTE: Immunoglobulin in the treatment of encephalitis
ISRCTN15791925Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Aug 2015
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, double-blind trial in encephalitis comparing Intravenous immunoglobulin + standard treatment with Matching placebo + standard treatment (2 arms). Primary endpoint: Good recovery at 12 months. Started Aug 2015; status: completed.
02
Drugs
immune globulin
03
Conditions
encephalitis
Beyond the preview
Go deeper on ISRCTN15791925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15791925.